Close

Medtronic (MDT) Receives FDA Approval of CapSureFix Novus MRI SureScan 5076 Lead

October 14, 2014 2:01 PM EDT Send to a Friend
Medtronic (NYSE: MDT) announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus MRI SureScan 5076 Lead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login